Answer
Avapritinib (Ayvakyt) is indicated as monotherapy for adults with unresectable or metastatic gastrointestinal stromal tumours (GIST) harbouring the platelet-derived growth factor receptor alpha (PDGFRA) D842V mutation.
Sources for this answer
- AYVAKYT 300 mg film-coated tabletsBlueprint Medicines (Netherlands) B.V. · emc · SmPC §4.1 Therapeutic Indications · Version 3Document updated
Sources checked